| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 221.16B | 224.09B | 219.61B | 211.53B | 212.82B | 206.01B |
| Gross Profit | 37.85B | 40.60B | 36.94B | 34.80B | 33.58B | 33.89B |
| EBITDA | 17.95B | 19.84B | 17.33B | 15.81B | 14.82B | 15.50B |
| Net Income | 6.60B | 7.36B | 6.51B | 5.31B | 5.25B | 5.98B |
Balance Sheet | ||||||
| Total Assets | 208.98B | 223.84B | 206.82B | 213.37B | 195.38B | 190.02B |
| Cash, Cash Equivalents and Short-Term Investments | 14.98B | 23.96B | 21.00B | 18.13B | 15.02B | 16.70B |
| Total Debt | 70.18B | 70.21B | 68.51B | 74.23B | 71.16B | 68.93B |
| Total Liabilities | 115.79B | 120.87B | 113.45B | 124.16B | 114.67B | 113.89B |
| Stockholders Equity | 92.45B | 102.15B | 92.73B | 88.62B | 80.20B | 75.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.37B | 7.80B | 4.05B | -2.42B | -994.00M |
| Operating Cash Flow | 0.00 | 15.17B | 18.14B | 11.12B | 7.01B | 16.70B |
| Investing Cash Flow | 0.00 | -10.65B | -8.26B | -9.29B | -9.39B | -18.22B |
| Financing Cash Flow | 0.00 | -2.18B | -7.05B | 1.05B | 535.00M | 4.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥78.43B | 21.16 | ― | 6.64% | 2.45% | 1.87% | |
72 Outperform | ¥64.74B | 7.56 | ― | 3.50% | 2.04% | 12.91% | |
70 Outperform | ¥13.19B | 10.20 | ― | 1.20% | 1.06% | -1.71% | |
69 Neutral | ¥63.18B | 15.41 | ― | 3.31% | 2.25% | 30.32% | |
63 Neutral | ¥97.18B | 12.05 | 7.53% | 3.01% | 5.17% | 20.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥18.44B | 7.18 | ― | 4.39% | 1.59% | -5.58% |